Form D · Other Health Care

Rebel Medicine Inc

Salt Lake City, UT · CIK 0002057423

Offering snapshot reported Jun 4, 2026 · SEC filing

Reported sold
$8.79M
Offering amount: $8.92M
Investors reported
43
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 7, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.39M$8.79MFeb 21, 2025: $6,065,000.00Feb 21, 2025Jun 4, 2026: $8,787,200.00Jun 4, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,065,000 → $8,787,200
  • Reported investors32 → 43

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 4, 2026Amendment$8,787,200$2,722,200vs Feb 21, 202543SEC filing
Feb 21, 2025Initial$6,065,000No comparison32SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-538907
$7,302,200 new money; $1,485,000 conversion of SAFEs

Source: Form D, filed Jun 4, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Brett Davis Director, Executive
Caleb Lade Director, Executive
Mai Nguyen Director
Kevin Passey Director
John Poyhonen Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
48 S Rio Grande Street
Salt Lake City, UT, 84101